The reiteration of a Buy rating and maintenance of a $200 price target by a reputable analyst like Joon Lee from Truist Securities is likely to instill confidence among investors and could positively influence Jazz Pharmaceuticals' stock price in the short term. Analyst ratings, especially from well-regarded financial institutions, often have a significant impact on stock prices as they can affect investor sentiment.